skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Secondary leukemia with a translocation (8; 21)

Journal Article · · Cancer Genet. Cytogenet.; (United States)

The clinical features and cytogenetic changes of acute myeloid leukemia (AML) developing 10 years after radiotherapy and chemotherapy (for osteosarcoma) are described. Features of both de novo AML (FAB M2 morphology, t(8;21), and secondary leukemia (additional cytogenetic changes, resistance to chemotherapy) were present. The importance of differentiation between primary and therapy-linked disease, and the difficulties in making such a distinction, are discussed.

Research Organization:
Selly Oak Hospital, Birmingham (England)
OSTI ID:
7130559
Journal Information:
Cancer Genet. Cytogenet.; (United States), Vol. 31:2
Country of Publication:
United States
Language:
English